Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells
Authors
Keywords
-
Journal
Viruses-Basel
Volume 15, Issue 3, Pages 672
Publisher
MDPI AG
Online
2023-03-03
DOI
10.3390/v15030672
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics
- (2022) Ilene Le et al. Vaccines
- PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses
- (2021) Yusuf Dölen et al. Frontiers in Immunology
- Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients
- (2021) Takeshi Ishikawa et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial
- (2021) Staffan Holmberg-Thydén et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
- (2021) Alexander J. Stephens et al. Frontiers in Immunology
- Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide
- (2021) Eugene Shenderov et al. Journal for ImmunoTherapy of Cancer
- Vaccines adjuvanted with an NKT cell agonist induce effective T-cell responses in models of CNS lymphoma
- (2020) Carole Grasso et al. Immunotherapy
- Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
- (2020) Afsheen Raza et al. Journal of Translational Medicine
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- Application of Bacteriophages in Nanotechnology
- (2020) Jan Paczesny et al. Nanomaterials
- Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery
- (2020) Alejandro González-Mora et al. Vaccines
- Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases
- (2020) Nicolás M. S. Gálvez et al. CLINICAL MICROBIOLOGY REVIEWS
- An Ig Transmembrane Domain Motif Improves the Function of TCRs Transduced in Human T Cells
- (2019) Luciana D’Apice et al. JOURNAL OF IMMUNOTHERAPY
- Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
- (2019) Luigi Aurisicchio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
- (2019) Yingting Zhang et al. Frontiers in Immunology
- The development of inovirus-associated vector vaccines using phage-display technologies
- (2019) Zachariah Stern et al. Expert Review of Vaccines
- Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies
- (2019) Rossella Sartorius et al. Pharmaceutics
- Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
- (2019) Anna Pavlick et al. Cancer Immunology Research
- Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control
- (2018) Yuki Kinjo et al. Frontiers in Immunology
- Vectorized Delivery of Alpha-GalactosylCeramide and Tumor Antigen on Filamentous Bacteriophage fd Induces Protective Immunity by Enhancing Tumor-Specific T Cell Response
- (2018) Rossella Sartorius et al. Frontiers in Immunology
- Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
- (2017) Melissa Bedard et al. Frontiers in Immunology
- Recombinant Phage Elicits Protective Immune Response against Systemic S. globosa Infection in Mouse Model
- (2017) Feng Chen et al. Scientific Reports
- Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins
- (2017) M. Speir et al. Scientific Reports
- The present status and future prospects of peptide-based cancer vaccines
- (2016) Masatoshi Hirayama et al. INTERNATIONAL IMMUNOLOGY
- Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1
- (2016) Sabrina Jutz et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response
- (2015) R. Sartorius et al. EMBO Molecular Medicine
- NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
- (2015) Regan J. Anderson et al. Chemical Science
- Phage therapy gets revitalized
- (2014) Sara Reardon NATURE
- A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy
- (2014) Regan J Anderson et al. Nature Chemical Biology
- Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies
- (2013) Girja S. Shukla et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hiding Lipid Presentation: Viral Interference with CD1d-Restricted Invariant Natural Killer T (iNKT) Cell Activation
- (2012) Daniëlle Horst et al. Viruses-Basel
- Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants
- (2011) Rossella Sartorius et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunological basis of M13 phage vaccine: Regulation under MyD88 and TLR9 signaling
- (2010) Shuhei Hashiguchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Translating Tumor Antigens into Cancer Vaccines
- (2010) Luigi Buonaguro et al. Clinical and Vaccine Immunology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now